Masoprocol Completed Phase 1 Trials for Neoplasms, Head and Neck Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00057512Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck